ProCE Banner Activity

Building Better Combination Strategies in MF Treatment

Slideset Download
In this downloadable slideset, John Mascarenhas, MD, reviews emerging combination strategies for patients with myelofibrosis, with a focus on areas of need in current therapy.

Released: December 14, 2017

Expiration: December 13, 2018

No longer available for credit.

Share

Faculty

John Mascarenhas

John Mascarenhas, MD

Director, Adult Leukemia Program
Leader, Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute 
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

Supported by an educational grant from

Incyte

Faculty Disclosure

Primary Author

John Mascarenhas, MD

Director, Adult Leukemia Program
Leader, Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute 
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

John Mascarenhas, MD, has disclosed that he has received consulting fees from Incyte and Novartis and funds for research support from CTI Biopharma, Incyte, Janssen, Merck, Novartis, Promedior, and Roche.